Antibody
0102030405
01
ADT1405-Mk-4721 Biosimilar-Anti-PSCA mAb-Research Grade
2025-04-25
- Catalog Number ADT1405
- Host CHO Cells
- Species Human
- Target PSCA
- Application Elisa, WB
Inquiry
detail
02
ADT1433-Neihulizumab Biosimilar-(PSGL1 / CD162)-Research Biosimilar Antibody
2025-04-25
Through continuous optimization by technical personnel, we can provide products with high specificity and affinity for target antigens
- Catalog Number ADT1433
- Host CHO Cells
- Species Mouse
- Target PSGL1 / CD162
- Application ELISA, FCM, BLI, SPR, Functional assay
Inquiry
detail
03
ADT1143-Cofetuzumab Biosimilar-(PTK7)-Research Biosimilar Antibody
2025-04-25
We test for a wide range of parameters, including potency, stability, and safety, so you can trust that our biosimilar antibodies will perform reliably in your research.
- Catalog Number ADT1143
- Host CHO Cells
- Species Human
- Target PTK7
- Application ELISA, WB
Inquiry
detail
04
ADT1047-Apamistamab Biosimilar-(PTPRC/CD45)-Research Biosimilar Antibody
2025-04-25
Alpha Lifetech specializes in providing high-quality, highly active, and high-purity biosimilar antibody products.
- Catalog Number ADT1047
- Host CHO Cells
- Species Human
- Target PTPRC/CD45
- Application ELISA, WB
Inquiry
detail
05
ADT1198-Elezanumab Biosimilar-(RGMA)-Research Biosimilar Antibody
2025-04-25
Alpha Lifetech uses advanced expression systems to produce high-quality biosimilar antibodies with enhanced efficiency.
- Catalog Number ADT1198
- Host CHO Cells
- Species Human
- Target RGMA
- Application ELISA, IHC, IF, IP, FCM, Functional assay
Inquiry
detail
06
ADT1059-Atorolimumab Biosimilar-(RHD/CD240D)-Research Biosimilar Antibody
2025-04-27
Through continuous optimization by technical personnel, we can provide products with high specificity and affinity for target antigens
- Catalog Number ADT1059
- Host CHO Cells
- Species Human
- Target RHD/CD240D
- Application ELISA, IHC, FC, IP, IF, Inhibition
Inquiry
detail
07
ADT1413-Morolimumab Biosimilar-(RHD/CD240D)-Research Biosimilar Antibody
2025-04-27
Alpha Lifetech offers expert biosimilar antibody customization services to meet specific research needs.
- Catalog Number ADT1413
- Host CHO Cells
- Species Human
- Target RHD/CD240D
- Application ELISA, WB
Inquiry
detail
08
ADT1556-Roledumab Biosimilar-(RHD)-Research Biosimilar Antibody
2025-04-27
We test for a wide range of parameters, including potency, stability, and safety, so you can trust that our biosimilar antibodies will perform reliably in your research.
- Catalog Number ADT1556
- Host CHO Cells
- Species Human
- Target RHD
- Application ELISA, WB
Inquiry
detail
09
ADT1567-RSV-neutralizing Human Antibody (D25) Biosimilar-(RSV)-Research Biosimilar Antibody
2025-04-27
Alpha Lifetech conducts comprehensive immunogenicity and stability testing on all of our biosimilar antibodies.
- Catalog Number ADT1567
- Host CHO Cells
- Species Human
- Target RSV
- Application ELISA, WB
Inquiry
detail
10
ADT1726-Zilovertamab Biosimilar-(ROR1)-Research Biosimilar Antibody
2025-04-27
Alpha Lifetech serves a global clientele, offering blocking antibodies to companies and researchers worldwide.
- Catalog Number ADT1726
- Host CHO Cells
- Species Mouse
- Target ROR1
- Application ELISA, FCM, BLI, SPR, Functional assay
Inquiry
detail
11
ADT1561-Rosmantuzumab Biosimilar-(RSPO3)-Research Biosimilar Antibody
2025-04-27
Whether using mammalian, bacterial, or yeast systems, our expression platform has been optimized to meet your specific needs, ensuring that the final product is reliable and suitable for your resea...
- Catalog Number ADT1561
- Host CHO Cells
- Species Mouse
- Target RSPO3
- Application ELISA, IHC, FC, IP, IF, Functional assay
Inquiry
detail
12
ADT1566-RSV-neutralizing Human Antibody (Am14) Biosimilar-(RSV)-Research Biosimilar Antibody
2025-04-27
Our services include everything from early-stage development to full-scale production, providing a comprehensive solution that meets your needs without breaking your budget.
- Catalog Number ADT1566
- Host CHO Cells
- Species Human
- Target RSV
- Application ELISA, WB
Inquiry
detail